The North America stem cell assay market is poised for significant growth in the coming years, driven by the ongoing advancements in stem cell research, substantial investments, and increasing adoption of stem cell-based therapies across various medical fields. In 2023, the market was valued at USD 7.1 billion, and it is expected to expand at a compound annual growth rate (CAGR) of 10.08% from...
The South Korea smart healthcare market is poised for remarkable growth over the coming years. With a projected CAGR of 8.1% from 2024 to 2032, the country's healthcare sector is on the verge of transformation. This growth is largely fueled by the government's strategic initiatives to digitalise healthcare and a robust emphasis on research and development (R&D). These efforts are not only...
The global Internet of Things global IoT in healthcare market has been experiencing exponential growth, with a valuation of USD 222.24 billion in 2023. This growth can be attributed to several factors, including rising disposable incomes, increasing healthcare expenditure, growing health awareness, and the rapid adoption of smart devices. These elements have collectively contributed to the...
The healthcare sector is increasingly relying on data analytics to optimise care delivery, enhance decision-making, and improve patient outcomes. The North American clinical data analytics in healthcare market is currently valued at USD 13.14 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 9.9% from 2024 to 2032, reaching an estimated value of USD 32.01...
The global medical cannabis market has witnessed significant growth in recent years, driven by increasing legalization, expanding therapeutic applications, and rising consumer acceptance. As of 2023, the market was valued at USD 10.20 billion and is projected to grow at a compound annual growth rate (CAGR) of 24.00% during the forecast period of 2024-2032, potentially reaching a market size of...
The North American hemoglobinopathies market is on a robust growth trajectory, with a projected compound annual growth rate (CAGR) of 5.10% during the forecast period of 2024-2032. This growth is primarily driven by the rising prevalence of sickle cell anemia and thalassemia, two major inherited blood disorders, along with significant advancements in treatment options and diagnostic...
Cardiometabolic diseases (CMDs) represent a range of conditions that affect the cardiovascular system and metabolism. These diseases, which include obesity, diabetes, hypertension, and cardiovascular diseases (CVDs), are becoming increasingly prevalent worldwide, particularly due to lifestyle changes and the aging global population. The global cardiometabolic disease market, valued at USD 34.1...
The global pharmacovigilance and drug safety software market is witnessing rapid growth, largely driven by the increasing need to monitor adverse drug reactions (ADRs) and ensure patient safety. With the global market valued at USD 8.50 billion in 2023, it is expected to expand at a CAGR of 9% from 2024 to 2032, reaching an estimated USD 18.43 billion by 2032. This growth is being propelled by...
The global aesthetic implants market has witnessed significant growth in recent years, driven by an increasing awareness of personal care, a growing desire for enhanced physical appearance, and rising disposable income across various regions. As of 2023, the market size reached a value of USD 4.58 billion and is projected to grow at a robust compound annual growth rate (CAGR) of 6.6% from 2024...
The in vitro diagnostics (IVD) market in Australia and New Zealand is witnessing significant growth and transformation. As the healthcare sector continues to evolve, the demand for advanced diagnostic tools is increasing across the region. The Australia and New Zealand IVD market size is expected to grow at a Compound Annual Growth Rate (CAGR) of 5.4% during the forecast period of 2024-2032....
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
